We, the Editors and Publishers of the Expert Collection journals note we have had cause to revisit the three articles listed below, post-publication, and the significant similarity in the text between these articles and other previously published articles has been identified as an issue of concern.
The three review articles published in Expert Collection journals are listed below followed by corresponding references to the published articles which have the highest level of similarity.
Derosa G Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 2012 Aug;12(8):1113-24.
[email protected] [email protected] [email protected]
Significant similarity and text overlap observed throughout [1] with the below article which has not been cited.
Arrigo Cicero & Sibel Ertek. Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results. Clin. Lipidol. (2009) 4(5), 553–563.
Significant similarity and text overlap observed throughout [1] with the below article.
Arrigo FG Cicero, Sibel Ertek. Berberine: metabolic and cardiovascular effects in preclinical and clinical trials Nutr Diet Suppl 2009 (2009) 1, 1–10*
Significant similarity and text overlap observed in section 4 in [1] with the below article which has not been cited.
Derosa G, Maffioli P. Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci. (2012) 8(5): 899–906.
Derosa G, Maffioli P. Drug safety evaluation of amlodipine. Expert Opin Drug Saf. 2011 Sep;10(5):795-804
[email protected] [email protected]
Significant similarity and text overlap observed in section 5 in [2] with the below article.
Stevo Julius, Michael A. Weber, Sverre E. Kjeldsen, Gordon T. McInnes, Alberto Zanchetti, Hans R. Brunner, John Laragh, M. Anthony Schork, Tsushung A. Hua, John Amerena, Ivan Balazovjech, Graham Cassel, Bela Herczeg, Nevres Koylan, Dieter Magometschnigg, Silja Majahalme, Felipe Martinez, Willie Oigman, Ricardo Seabra Gomes, Jun-ren Zhu. The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) Trial Outcomes in Patients Receiving Monotherapy. Hypertension (2006) 48:385-391. *
Significant similarity and text overlap observed in section 5 in [2] with the below article which has not been cited.
Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Gravina A, Mereu R, D’Angelo A, Palumbo I, Randazzo S, Cicero AF. Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med. 2010;49(16):1717-25.
Derosa G, Maffioli P. Nutraceuticals for the treatment of metabolic diseases: evidence from clinical practice. Expert Rev. Endocrinol. Metab. 10(3), 297–304 (2015)
[email protected] [email protected]
Significant similarity and text overlap observed throughout [3] with the below article which has not been cited.
Giuseppe Derosa, Celina Preciado Limas, Pilar Ceballos Macías, Aceves Estrella, Pamela Maffioli. Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci. (2014) 10(2): 336–344.
Significant similarity and text overlap observed throughout [3] with the below article which has not been cited.
Giuseppe Derosa, Pamela Maffioli. Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practice. Arch Med Sci (2012) 8, 5: 899-906
*These articles have been cited and referenced however appropriate acknowledgement for the high extent of overlap was not given and could be misleading to the reader as being original.